Monthly Archives: April 2022
CAS-AM: Week 1, Day 4
CAS-AM: Shaping the Future of Thrombosis Care Day 4 and last day of the 1st week of the CAS-AM antithrombotic management course. Closing the week with great lectures by experts on antiphospholipid syndrome (Stéphane ZUILY, @Rolf Urbanus), thrombosis and pregnancy … Continue reading
CAS-AM: Week 1, Day 3
CAS-AM: Shaping the Future of Thrombosis Care Update on day 3 of the CAS-AM antithrombotic management course. Realizing that a course is all about good, enthusiastic, and integrating participants, a snapshot into the hard work that they deliver. From pre-discussions in team sessions to small … Continue reading
CAS-AM: Week 1, Day 2
CAS-AM: Shaping the Future of Thrombosis Care During the 2nd training day on antithrombotic management, participants started with a lively post discussion on VTE and cancer, guided with great enthusiasm by Nick van Es and Marcello Di Nisio. The lead-out … Continue reading
CAS-AM: Week 1, Day 1
CAS-AM: Shaping the Future of Thrombosis Care The first day of the CAS-AM course started with an introduction by Hugo Ten cate, followed by the 1st case on antithrombotic management in cancer associated venous thrombosis. Two tutorial groups followed the … Continue reading
Thrombin in complex with dabigatran can still interact with PAR-1 via exosite-I and instigate loss of vascular integrity.
Dólleman SC, Agten SM, Spronk HMH, Hackeng TM, Bos MHA, Versteeg HH, van Zonneveld AJ, de Boer HC. J Thromb Haemost. 2022 Apr;20(4):996-1007. PMID: 35037739 Background: Atrial fibrillation (AF) can lead to the loss of microvascular integrity thereby enhancing AF … Continue reading
Posted in publications, research
Leave a comment
NVTH PhD Course Lecture
Presentation on the “Introduction in Coagulation, Natural Anticoagulants and Thrombosis” for the NVTH PhD Course on Venous Thrombosis in Koudekerke, The Netherlands.